Cited by 64Nonmelanoma Skin Cancer StudiesPhotodynamic Therapy Research StudiesSkin Protection and Aging

Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers

Tarstedt, M., Gillstedt, M., Wennberg Larkö, A.‐M., Paoli, J.·2016·Journal of the European Academy of Dermatology and Venereology

Abstract

BACKGROUND: Topical photodynamic therapy (PDT) is an effective treatment for superficial non-melanoma skin cancers. Two prodrugs, 5-aminolevulinic acid (ALA) and methyl aminolevulinate (MAL), are available for clinical use. There is, however, a lack of studies comparing the clinical effectiveness of these two prodrugs. OBJECTIVE: The objective of the study was to compare the clinical response between ALA- and MAL-PDT when treating actinic keratosis (AK), Bowen's disease (BD), nodular basal cell carcinoma (nBCC) and superficial basal cell carcinoma (sBCC). METHODS: During the period 2002-2009, patients with AK, BD, nBCC and sBCC were treated with ALA- and MAL-PDT at the Department of Dermatology at Karlskoga Hospital in Sweden using a fixed protocol. All patients were followed up approximately 6 months after treatment to evaluate the clinical results, which were analysed retrospectively. RESULTS: In total, 116 patients with 203 tumours were treated with PDT during the study period. ALA- and MAL-PDT were used for 24 vs. 44 AK fields, 9 vs. 18 BD lesions, 19 vs. 25 nBCCs and 25 vs. 39 sBCCs. Response rates with ALA- and MAL-PDT, respectively, were 63% and 75% for AK, 89% and 78% for BD, 84% and 84% for nBCC and 88% and 87% for sBCC. There were no statistically significant differences in the complete clinical response rates for ALA- and MAL-PDT when used for any of the four lesion types. CONCLUSION: ALA- and MAL-PDT appear to be equally effective in the treatment of AK, BD, nBCC and sBCC. Nevertheless, larger, prospective, randomized and controlled studies should be carried out to confirm these results.

Integrity signals

Registry

Crossref · 10.1111/jdv.13558

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A study comparing ALA/PDT to MAL/PDT with 9 and 18 Bowen's disease lesions, respectively, showed an 89% and 78% response rate, respectively, at approximately 6 months after treatment.

    “A study comparing ALA/PDT to MAL/PDT with 9 and 18 Bowen’s disease lesions, respectively, showed an 89% and 78% response rate, respectively, at approximately 6 months after treatment [59].”

    From Photodynamic Therapy for Non-Melanoma Skin Cancers (2016) · cites this paper as [59]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tarstedt, M., Gillstedt, M., Wennberg Larkö, A. ‐., & Paoli, J.
Affiliations
  • Department of Dermatology Karlskoga Hospital Karlskoga Sweden
  • Sahlgrenska University Hospital (SE)
  • Department of Dermatology and Venereology Sahlgrenska University Hospital Institute of Clinical Sciences at the Sahlgrenska Academy University of Gothenburg Gothenburg Sweden
Corresponding author
Paoli, J.
Venue
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Published
2016-02-03
Volume
30
Issue
3
Pages
420-423
ISSN
  • 0926-9959 (ISSN-L)
  • 1468-3083
OpenAlex
W2320951753
Cited by
63
References
22
Citations by year
2026: 3 · 2025: 8 · 2024: 8 · 2023: 4 · 2022: 7 · 2021: 3 · 2020: 4 · 2019: 8 · 2018: 7 · 2017: 5 · 2016: 6
FWCI
8.13
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the European Academy of Dermatology and Venereology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Nonmelanoma Skin Cancer Studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Photodynamic Therapy Research Studies
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
Keywords
topical photodynamic therapy, 5-aminolevulinic acid, methyl aminolevulinate, non-melanoma skin cancer, actinic keratosis, Bowen's disease, nodular basal cell carcinoma, superficial basal cell carcinoma, treatment response
MeSH terms
Adult, Aged, Aged, 80 and over, Aminolevulinic Acid, Basal Cell Carcinoma, Carcinoma, Basal Cell, Female, Follow-Up Studies, Humans, Male, Melanoma, Middle Aged, Retrospective Studies, Skin Neoplasms, Treatment Outcome, Photosensitizing Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review